Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2025
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Journal: JAMA neurology
Published: October 23, 2023
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: February 08, 2022
The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016-2018: The Ohio Population-Based ALS Registry.
Journal: Neuroepidemiology
Published: October 08, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Journal: Muscle & nerve
Published: September 04, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
Journal: The New England journal of medicine
Published: September 03, 2020
Risk factors for amyotrophic lateral sclerosis: A regional United States case-control study.
Journal: Muscle & nerve
Published: May 27, 2020
Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohort.
Journal: Neurology. Genetics
Published: July 16, 2019
Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patients.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: April 02, 2019
Last Updated: 09/26/2026